MedCity News October 18, 2024
Jan Schulte

Organizations are delivering digital experiences and content to HCPs on a much larger scale than was previously possible. Integrating digital tools will advance things even further and help marketers and MLR teams maintain brand consistency and ensure compliance across digital and content operations.

What a difference a few years make. Previously, digital strategy in the biopharma industry consisted of a series of isolated projects and fragmented channels, websites, and portals. Today, omnichannel digital engagement is the way of doing business, driven by declining in-person access to healthcare professionals (HCPs).

Over this time, the number of digital-savvy HCPs has increased, as physicians prefer to engage biopharma brands in a variety of digital channels. At the center of the industry’s transformation is...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Provider
Gene Therapy for Cardiomyopathies Presents Promising Alternative to Current Treatment
STAT+: 3 trends to watch in biotech in 2025
CVS, Walgreens & Walmart's healthcare strategy faces headwinds: 10 notes from 2024
The GLP-1 dilemma persists into 2025
The Chase for Novel Oral GLP-1 Obesity Meds Adds a New Contender

Share This Article